BR1100704KB1 - recombinant vector, method for producing a DNA, method for producing a polypeptide, methods using said polypeptide, and a strain of Escherichia coli. - Google Patents

recombinant vector, method for producing a DNA, method for producing a polypeptide, methods using said polypeptide, and a strain of Escherichia coli.

Info

Publication number
BR1100704KB1
BR1100704KB1 BRPP1100704-4KB1A BR1100704A BR1100704KB1 BR 1100704K B1 BR1100704K B1 BR 1100704KB1 BR 1100704 A BR1100704 A BR 1100704A BR 1100704K B1 BR1100704K B1 BR 1100704KB1
Authority
BR
Brazil
Prior art keywords
polypeptide
producing
dna
strain
methods
Prior art date
Application number
BRPP1100704-4KB1A
Other languages
Portuguese (pt)
Inventor
Katsutoshi Sasaki
Kazumi Miura
Nobuo Hanai
Tatsunari Nishi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13390376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100704K(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of BR1100704KB1 publication Critical patent/BR1100704KB1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
BRPP1100704-4KB1A 1993-03-29 1997-05-08 recombinant vector, method for producing a DNA, method for producing a polypeptide, methods using said polypeptide, and a strain of Escherichia coli. BR1100704KB1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6901693 1993-03-29

Publications (1)

Publication Number Publication Date
BR1100704KB1 true BR1100704KB1 (en) 2011-10-18

Family

ID=13390376

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPP1100704-4KB1A BR1100704KB1 (en) 1993-03-29 1997-05-08 recombinant vector, method for producing a DNA, method for producing a polypeptide, methods using said polypeptide, and a strain of Escherichia coli.

Country Status (8)

Country Link
US (2) US7094530B1 (en)
EP (1) EP0643132B1 (en)
JP (1) JP3756946B2 (en)
BR (1) BR1100704KB1 (en)
DE (1) DE69434749T2 (en)
HK (1) HK1012028A1 (en)
SG (1) SG49117A1 (en)
WO (1) WO1994023021A1 (en)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595900A (en) * 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
SG49117A1 (en) 1993-03-29 1998-05-18 Kyowa Hakko Kogyo Kk Alfa -1, 3-fucosyltransferase
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US5770420A (en) * 1995-09-08 1998-06-23 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
EP0888377B1 (en) * 1996-03-08 2007-12-12 The Regents Of The University Of Michigan MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
WO1999048926A1 (en) * 1998-03-24 1999-09-30 Kyowa Hakko Kogyo Co., Ltd. ANTIBODY AGAINST HUMAN α1,3-FUCOSE TRANSFERASE Fuc-TVII
AT408446B (en) 1999-02-18 2001-11-26 Altmann Friedrich Dr FUCOSYL TRANSFERASE GENE
ES2420835T3 (en) 1999-04-09 2013-08-27 Kyowa Hakko Kirin Co., Ltd. Procedure to control the activity of immunofunctional molecules
HUP0302299A2 (en) * 2000-05-12 2003-10-28 Neose Technologies, Inc. In vitro fucosylation recombinant glycopeptides
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
MXPA04012496A (en) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Pegylated factor vii glycoforms.
KR101043562B1 (en) 2002-12-26 2011-06-22 교와 핫꼬 바이오 가부시키가이샤 Process for producing dipeptide
CA2519092C (en) 2003-03-14 2014-08-05 Neose Technologies, Inc. Branched water-soluble polymers and their conjugates
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
US20070026485A1 (en) 2003-04-09 2007-02-01 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2006127896A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
ES2560657T3 (en) 2004-01-08 2016-02-22 Ratiopharm Gmbh O-linked glycosylation of G-CSF peptides
US8257943B2 (en) 2004-06-25 2012-09-04 Kyowa Hakko Bio Co., Ltd. Process for producing dipeptides or dipeptide derivatives
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
EP1799249A2 (en) 2004-09-10 2007-06-27 Neose Technologies, Inc. Glycopegylated interferon alpha
DK2586456T3 (en) 2004-10-29 2016-03-21 Ratiopharm Gmbh Conversion and glycopegylation of fibroblast growth factor (FGF)
JP4951527B2 (en) 2005-01-10 2012-06-13 バイオジェネリックス アーゲー GlycoPEGylated granulocyte colony stimulating factor
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
FI20055398A0 (en) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Method for evaluating cell populations
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
WO2007066698A1 (en) 2005-12-06 2007-06-14 Kyowa Hakko Kogyo Co., Ltd. Genetically recombinant anti-perp antibody
EP1978094B1 (en) 2005-12-27 2012-03-14 Kyowa Hakko Bio Co., Ltd. Method for production of l-glutamine
CN101511870B (en) 2006-06-06 2014-04-09 协和发酵麒麟株式会社 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
WO2008011633A2 (en) 2006-07-21 2008-01-24 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
US7939294B2 (en) 2006-09-25 2011-05-10 Kyowa Hakko Bio Co., Ltd. DNA encoding proteins having dipeptide-synthesizing activity and methods of using the same
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
WO2008090960A1 (en) 2007-01-24 2008-07-31 Kyowa Hakko Kirin Co., Ltd. Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
KR101578940B1 (en) 2007-01-24 2015-12-18 교와 핫꼬 기린 가부시키가이샤 Genetically recombinant antibody composition having enhanced effector activity
US20100075343A1 (en) 2007-01-25 2010-03-25 Motoo Yamasaki Novel peptides
SG187521A1 (en) * 2007-03-07 2013-02-28 Glycofi Inc Production of glycoproteins with modified fucosylation
WO2008114733A1 (en) 2007-03-16 2008-09-25 Kyowa Hakko Kirin Co., Ltd. Anti-claudin-4 antibody
CA2682897C (en) 2007-04-03 2016-11-22 Biogenerix Ag Methods of treatment using glycopegylated g-csf
MX2009013259A (en) 2007-06-12 2010-01-25 Novo Nordisk As Improved process for the production of nucleotide sugars.
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
KR20100097674A (en) 2007-12-05 2010-09-03 교와 핫꼬 기린 가부시키가이샤 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
PL2257311T3 (en) 2008-02-27 2014-09-30 Novo Nordisk As Conjugated factor viii molecules
US9023999B2 (en) 2008-06-30 2015-05-05 Kyowa Hakko Kirin Co., Ltd Anti-CD27 antibody
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
JP5730570B2 (en) 2008-07-17 2015-06-10 協和発酵キリン株式会社 Anti-system ASC amino acid transporter 2 (ASCT2) antibody
KR20110069138A (en) 2008-10-09 2011-06-22 교와 메덱스 가부시키가이샤 Novel fructosyl peptide oxidase
ES2602459T3 (en) 2008-12-26 2017-02-21 Kyowa Hakko Kirin Co., Ltd. Anti-CD4 antibody
PT2423228E (en) 2009-04-20 2016-02-26 Kyowa Hakko Kirin Co Ltd Antibody containing igg2 having amino acid mutation introduced therein
EP2543727B1 (en) 2010-03-02 2016-08-31 Kyowa Hakko Kirin Co., Ltd. Modified antibody composition
PL2581113T3 (en) 2010-06-11 2018-11-30 Kyowa Hakko Kirin Co., Ltd. Anti-tim-3 antibody
EP2610338A4 (en) 2010-08-02 2015-03-25 Kyowa Hakko Kirin Co Ltd Method for producing substance
WO2012091023A1 (en) 2010-12-27 2012-07-05 協和発酵キリン株式会社 Method for preparing aqueous solution containing culture medium and chelating agent
CA2840461A1 (en) 2011-06-20 2012-12-27 Kyowa Hakko Kirin Co., Ltd. Anti-erbb3 antibody
EP2852610B1 (en) 2012-05-23 2018-07-11 Glykos Finland Oy Production of fucosylated glycoproteins
EP2868667B1 (en) 2012-07-02 2019-01-30 Kyowa Hakko Kirin Co., Ltd. Therapeutic agent for anemia including renal anemia and cancer-induced anemia which contains anti-bmp9 antibody as active ingredient
EP2930240B1 (en) 2012-12-07 2018-08-01 Kyowa Hakko Kirin Co., Ltd. Anti-folr1 antibody
CN105431533B (en) 2013-07-09 2019-06-28 协和梅迪克斯株式会社 Be saccharified hexapeptide oxidizing ferment and application thereof
US10513724B2 (en) 2014-07-21 2019-12-24 Glykos Finland Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
WO2016040531A1 (en) * 2014-09-09 2016-03-17 Glycosyn LLC Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides
CN110959014B (en) 2017-07-18 2024-01-16 协和麒麟株式会社 Anti-human CCR1 monoclonal antibodies
JP6807089B2 (en) 2017-07-26 2021-01-06 Ｓｐｉｂｅｒ株式会社 Modified fibroin
CA3081854A1 (en) 2017-11-08 2019-05-16 Kyowa Kirin Co., Ltd. Bispecific antibody which binds to cd40 and epcam
AU2018384239A1 (en) 2017-12-12 2020-07-02 Kyowa Kirin Co., Ltd. Anti-BMP10 antibody, and therapeutic agent for hypertension and hypertensive diseases comprising said antibody as active ingredient
TW202012445A (en) 2018-06-26 2020-04-01 日商協和麒麟股份有限公司 Antibody binding to chondroitin sulfate proteoglycan-5
JP7397445B2 (en) 2018-06-26 2023-12-13 協和キリン株式会社 Antibody that binds to Cell Adhesion Molecule 3
US20210403971A1 (en) 2018-11-02 2021-12-30 Kyowa Kirin Co., Ltd. Method for preparing liquid medium
TW202039581A (en) 2018-12-28 2020-11-01 日商協和麒麟股份有限公司 Bispecific antibody binding to TfR
US20220119463A1 (en) 2019-01-09 2022-04-21 Spiber Inc. Modified fibroin
US20220259328A1 (en) 2019-05-15 2022-08-18 Kyowa Kirin Co., Ltd. Bispecific antibody binding to cd40 and fap
TW202108625A (en) 2019-05-15 2021-03-01 日商協和麒麟股份有限公司 Bispecific antibody capable of binding to cd40 and gpc3
TW202140561A (en) 2020-02-14 2021-11-01 日商協和麒麟股份有限公司 Bispecific antibody that binds to CD3
KR20220155328A (en) 2020-03-16 2022-11-22 스파이버 가부시키가이샤 Synthetic polymer and its manufacturing method, molding material, and molded article
CN112795583A (en) * 2020-11-16 2021-05-14 上海大学 Preparation method of recombinant sialic acid exonuclease, expression gene, recombinant expression vector and construction method
CN117836326A (en) 2021-08-26 2024-04-05 协和麒麟株式会社 Bispecific antibodies that bind to CD116 and CD131

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
ATE188999T1 (en) 1990-02-14 2000-02-15 Univ Michigan METHOD AND PRODUCTS FOR THE SYNTHESIS OF OLIGOSACCHARIDE STRUCTURES ON GLYCOPROTEINS, GLYCOLIPIDS OR AS FREE MOLECULES
US5595900A (en) 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
SG49117A1 (en) 1993-03-29 1998-05-18 Kyowa Hakko Kogyo Kk Alfa -1, 3-fucosyltransferase

Also Published As

Publication number Publication date
EP0643132A1 (en) 1995-03-15
DE69434749D1 (en) 2006-07-06
US20060246468A1 (en) 2006-11-02
EP0643132B1 (en) 2006-05-31
US7709234B2 (en) 2010-05-04
EP0643132A4 (en) 1999-01-13
DE69434749T2 (en) 2007-04-26
SG49117A1 (en) 1998-05-18
US7094530B1 (en) 2006-08-22
JP3756946B2 (en) 2006-03-22
HK1012028A1 (en) 1999-07-23
WO1994023021A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
BR1100704KB1 (en) recombinant vector, method for producing a DNA, method for producing a polypeptide, methods using said polypeptide, and a strain of Escherichia coli.
BR9713294A (en) "antibodies against protein related to human parathyroid hormone"
BR9205834A (en) Radiotelephony system, and verification process of a target channel.
BR9810654B8 (en) Method of Preparing a Polypeptide, Antibody Molecules and Composition.
EP0660234A3 (en) Method and system for executing code remotely.
FI943389A (en) Bacillus from Bacillus, expression vector for such xylanase and other proteins, their host organisms and use
EP0632286A3 (en) Self-calibrating, eigenstructure based method and means of direction finding.
BRPI9600729B8 (en) expression vector, transgenic microorganism, process for cloning a nucleic acid and process for preparing a protein and transformed yeast strain
NO910982L (en) URATOXYDASE-ACTIVE PROTEIN, RECOMBINANT GENE CODING IT, EXPRESSION VECTOR, MICROORGANISMS AND TRANSFORMER CELLS.
KR960704045A (en) E. coli csrA gene, protein encoded by it and its use (THE ESCHERICHIA COLI carA GENE, PROTEIN ENCODED THEREBY, AND MITHODS OF USE THEREOF)
BR9202785A (en) VALVE ASSEMBLY ASSEMBLY PROCESS FOR ALTERNATE MOVEMENT PISTON COMPRESSOR AND THEIR COMPRESSOR
EP0759470A3 (en) Gene encoding endoglycoceramidase activator
AU7690896A (en) Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific t-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide
AU676277B2 (en) DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
BR9306150A (en) Endo - 1,4-glucanase DNA sequence recombinant transformed host vector containing the process vector for the production of endo--1,4-glucanase enzyme preparation and use of endo--1,4-glucanase
NO995959L (en) DNA sequence, vector, transformed eukaryotic or prokaryotic host cells, processes for producing a protein, polypeptide, antibody, isolation and identification method, pharmaceutical composition and screening method.
ITGE930084A0 (en) SAFE, PARTICULARLY FOR UNDER GUNS OR SIMILAR.
DK509985D0 (en) ANTIBIOTIC POLYPEPTIDE, PROCEDURE FOR ITS MANUFACTURING AND ITS USE
ITGE930005A0 (en) SPAR FURNACE FOR ACCELERATED HEATING OF BILLETS, OR SIMILAR.
DK312787A (en) POLYPEPTIDES, PROCEDURES FOR THEIR PREPARATION, DNA CODING THE POLYPEPTIDES, VECTORS CONTAINING SUCH REVENUES AND MEDICINALS CONTAINING POLYPEPTIDES
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
CA2194032A1 (en) Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein
NO981707L (en) Xylanase, oligonucleotide sequence encoding xylanase and its use
DK0814077T3 (en) Benzoylguanidines, processes for their preparation, and pharmaceuticals containing them
MX9709473A (en) Adherence gene from helicobacter pylori and polypeptide coded thereby.